½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå : Á¦Ç° À¯Çüº°, ÀÌ½Ä °¡´É¼ºº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°
Cardiac Pacemaker Market, By Product Type, By Implantability, By End User, By Geography
»óǰÄÚµå : 1673833
¸®¼­Ä¡»ç : Coherent Market Insights
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹®
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,500 £Ü 6,354,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 7,000 £Ü 9,884,000
PDF (Multi User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷Àå¿¡¼­ 7¸í±îÁö ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 10,000 £Ü 14,120,000
PDF (Enterprise User License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

¼¼°èÀÇ ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀåÀº 2025³â¿¡ 51¾ï 5,800¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2032³â¿¡´Â 73¾ï 1,120¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â¿¡ CAGR 5.1%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 51¾ï 5,800¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£ : 2025-2032³â CAGR 5.10% 2032³â ±Ý¾× ¿¹Ãø 73¾ï 1,120¸¸ ´Þ·¯
µµÇ¥. 2025³â Áö¿ªº° ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå Á¡À¯À²(%), 2025³â
Cardiac Pacemaker Market-IMG1

½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ¼¼°è ½ÃÀåÀº ½ÉÇ÷°ü ÁúȯÀÇ Àü ¼¼°è À¯º´·ü Áõ°¡·Î ÀÎÇØ Áö³­ ¼ö³â°£ Å« ¼ºÀåÀ» ÀÌ·ç¾ú½À´Ï´Ù. ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿´Â ½ÉÀåÀÇ ÁÖ¿ä ¹æ¿¡ Àü±â ÆÞ½º¸¦ °ø±ÞÇÏ¿© ±ÔÄ¢ÀûÀÎ ½ÉÀå ¹Úµ¿À» À¯ÁöÇÏ´Â µ¥ µµ¿òÀÌ µÇ´Â ÀÇ·á±â±âÀÔ´Ï´Ù. ºÎÁ¤¸Æ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡¿Í ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ÀåºñÀÇ ±â¼ú ¹ßÀüÀº ¿¹Ãø ±â°£ Áß ½ÃÀå ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹»óµÇ´Â ÁÖ¿ä ¿äÀÎ Áß ÀϺÎÀÔ´Ï´Ù. ±×·¯³ª Àåºñ ÇÕº´ÁõÀÇ À§Çè°ú ´ëü Ä¡·áÀÇ °¡¿ë¼ºÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

¼¼°è ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå ¼ºÀåÀÇ ¿øµ¿·ÂÀº ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ºÎÁ¤¸Æ À§ÇèÀÌ ³ôÀº ³ëÀÎ Àα¸ Áõ°¡·Î, ¼¼°èº¸°Ç±â±¸(WHO) ÀÚ·á¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀº Àü ¼¼°è »ç¸Á ¿øÀÎ 1À§·Î ¸Å³â 1,700¸¸ ¸í ÀÌ»óÀÌ ½ÉÀ帶ºñ¿Í ³úÁ¹ÁßÀ¸·Î ¸ñ¼ûÀ» ÀÒ°í ÀÖ½À´Ï´Ù. ¶ÇÇÑ ¼ÒÇüÈ­¿Í ¹èÅ͸® ¼ö¸í ¿¬Àå¿¡ ÃÊÁ¡À» ¸ÂÃá ±â¼ú Çõ½ÅÀ¸·Î ½É¹ÚÁ¶À²±â À̽ÄÀÇ ÀûÀÀÁõÀÌ È®´ëµÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ½É¹ÚÁ¶À²±â ¼ö¼ú¿¡ µû¸¥ ³ôÀº ºñ¿ë°ú ¸®µå °áÇÔ ¹× °¨¿°°ú °°Àº ±â±â ÇÕº´Áõ À§ÇèÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¸ñÂ÷

Á¦1Àå Á¶»çÀÇ ¸ñÀû°ú ÀüÁ¦Á¶°Ç

Á¦2Àå ½ÃÀå Àü¸Á

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

Á¦4Àå ¼¼°èÀÇ ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå, Á¦Ç° À¯Çüº°, 2020-2032³â

Á¦6Àå ¼¼°èÀÇ ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå, ÀÌ½Ä °¡´É¼ºº°, 2020-2032³â

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â

Á¦8Àå ¼¼°èÀÇ ½ÉÀå ÆäÀ̽º¸ÞÀÌÄ¿ ½ÃÀå, Áö¿ªº°, 2020-2032³â

Á¦9Àå °æÀï ±¸µµ

Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ ±ÇÀå»çÇ×

Á¦11Àå Âü°í ¹®Çå°ú Á¶»ç ¹æ¹ý

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Cardiac Pacemaker Market is estimated to be valued at USD 5,158.0 Mn in 2025 and is expected to reach USD 7,311.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 5.1% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 5,158.0 Mn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 5.10% 2032 Value Projection: USD 7,311.2 Mn
Figure. Cardiac Pacemaker Market Share (%), By Region 2025
Cardiac Pacemaker Market - IMG1

Global cardiac pacemaker market has been witnessing significant growth over the past few years, owing to rising prevalence of cardiovascular diseases worldwide. Cardiac pacemaker is a medical device that helps to maintain regular heart beats by delivering electrical pulses to key chambers of the heart. Growing geriatric population who are more susceptible to arrhythmia and technological advancements in pacemaker devices are some of the major factors that are expected to drive the market growth during the forecast period. However, risk of device complications and availability of alternative treatments can hamper the market growth.

Market Dynamics:

Global cardiac pacemaker market growth is driven by rising incidence of cardiovascular diseases and increasing elderly population base globally who are at high risk of arrhythmias. According to the data by WHO, cardiovascular diseases are the leading cause of deaths worldwide with over 17 million lives lost each year due to heart attacks and strokes. Moreover, technological innovations with focus on miniaturization and battery longevity have expanded indications for pacemaker implants. However, high costs associated with pacemaker procedures and risk of device complications such as lead defects and infections can hamper the market growth.

Key Features of the Study:

Detailed Segmentation-

Table of Contents

1. Research Objectives and Assumptions

2. Market Purview

3. Market Dynamics, Regulations, and Trends Analysis

4. Global Cardiac Pacemaker Market - Impact of Coronavirus (COVID-19) Pandemic

5. Global Cardiac Pacemaker Market, By Product Type, 2020 - 2032, (USD Mn)

6. Global Cardiac Pacemaker Market, By Implantability, 2020 - 2032, (USD Mn)

7. Global Cardiac Pacemaker Market, By End User, 2020 - 2032, (USD Mn)

8. Global Cardiac Pacemaker Market, By Region, 2020 - 2032, (USD Mn)

9. Competitive Landscape

10. Analyst Recommendations

11. References and Research Methodology

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â